PGC-1α expression analysis during PV+ interneuron development

PRIMARY OUTCOME

PGC-1α expression levels during development

EXPECTED OUTCOMES

## Primary Outcomes **Wild-Type Developmental Profile**: In control PV-Cre mice, PGC-1α expression in PV+ interneurons follows a biphasic pattern: low at early stages (E14.5-P0, <10% of PV+ cells), peak at critical period (P7-P14, 40-60% of PV+ cells), and sustained into adulthood (P21, 25-35% of PV+ cells). **PGC-1α cKO Phenotype**: PV-specific PGC-1α deletion results in: (a) reduced PV+ interneuron density at P14 (-30% vs. controls, p < 0.01), (b) altered interneuron morphology (somal size reduction ≥15%, p < 0.05), and (c) delayed PV protein expression (≥2 day shift in 50% PV+ milestone). ## Secondary Outcomes **Mitochondrial Consequences**: PGC-1α cKO PV+ interneurons show reduced mitochondrial density (electron microscopy morphometry, -25%, p < 0.05) and impaired spatial learning (water maze probe trial, -35% target quadrant preference vs. controls).

SUCCESS CRITERIA

## Primary Success Criteria **Cell-Type Specific Deletion**: PGC-1α protein must be reduced by ≥85% in PV+ interneurons in cKO vs. control (Western blot of FACS-sorted PV+ cells), while PGC-1α levels in non-PV neurons must remain unchanged (control for systemic effects). **Functional Impact**: PGC-1α cKO must produce significant behavioral or electrophysiological phenotype by P30: either (a) ≥30% reduction in PV+ cell density in prefrontal cortex, or (b) ≥20% impairment in working memory (Y-maze alternation) vs. controls. ## Secondary Success Criteria **Developmental Timing**: PGC-1α expression must peak between P7-P14 in wild-type PV+ interneurons, corresponding to the critical period for PV+ interneuron circuit maturation. cKO must show altered developmental trajectory with significant departure from this temporal pattern. **Compensatory Upregulation**: Other PGC-1 family members (PGC-1β, PERC) must not show significant compensatory upregulation in cKO PV+ interneurons (≤1.3-fold change vs. controls), confirming specific PGC-1α contribution.

PROTOCOL

# PGC-1α Expression Analysis During PV+ Interneuron Development Protocol ## Phase 1: Mouse Breeding and Genotyping (Days 1-14) **Breeding Strategy**: Cross PGC-1α flox/flox (B6;129-Ppargc1a<tm1.1Dlb>/J, JAX #024119) with PV-Cre driver line (B6;129P2-Pvalb<tm1(cre)Jpb>/J, JAX #017493) to generate PV-Cre;PGC-1α flox/flox conditional knockout (cKO) and Cre-negative PGC-1α flox/flox controls. Genotype via PCR (primer sets for Cre, flox, WT alleles). **Timed Pregnancy Setup**: Set up overnight timed matings (vaginal plug = E0.5). Harvest embryos at E14.5, E17.5, P0, P7, P14, and P21 (n≥4 per genotype per timepoint). Genotype and sex-label all specimens. **Tissue Processing**: Dissect cerebral cortex, fix in 4% PFA (24 hours, 4°C), cryoprotect in 30% sucrose, and embed in OCT. Cut coronal sections (20 μm) on a cryostat. Mount every 6th section for systematic sampling. ## Phase 2: Immunohistochemical Staining (Days 15-21) **Multi-plex Staining**: Perform immunohistochemistry on brain sections using Opal 4-color fluorescence kit (PerkinElmer). Stain sequence: PV (1:1000, Swant #P308), PGC-1α (1:200, Abcam #ab191695), Ki67 (proliferation marker, 1:200, Abcam #ab15580), and DAPI nuclear counterstain. Include no-primary and no-secondary controls for each run. **Image Acquisition**: Image on Vectra 3.0 automated fluorescence microscope (20× objective) at 5 pre-frontal cortical fields per section (n=3 sections per animal). Acquire at consistent exposure settings for each channel across all samples. ## Phase 3: Quantification and Spatial Analysis (Days 22-35) **Cell Counting**: Use HALO software (Indica Labs) for automated cell detection and classification. Define PV+ cells as PV fluorescence > 3× background threshold. Quantify PGC-1α+ cells as percentage of PV+ population at each developmental stage. Count Ki67+PV+ double-positive cells to assess proliferation rates. **Developmental Trajectory Analysis**: Plot PGC-1α expression frequency in PV+ interneurons from E14.5 to P21 for both cKO and control genotypes. Fit polynomial or logistic growth curves to characterize expression trajectory parameters (peak timing, plateau level). **Statistical Analysis**: Compare cKO vs. control at each timepoint via two-way ANOVA (genotype × age) with Bonferroni post-hoc correction. Primary outcome: area under the PGC-1α+ developmental curve.

LINKED HYPOTHESES

Related Target

HTML iframe

<iframe src="http://scidex.ai/artifact/exp-2c0ab84a-4abe-4641-8ec8-c8a09ace7ae2?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>

Markdown link

[PGC-1α expression analysis during PV+ interneuron development](http://scidex.ai/artifact/exp-2c0ab84a-4abe-4641-8ec8-c8a09ace7ae2)

Direct URL

http://scidex.ai/artifact/exp-2c0ab84a-4abe-4641-8ec8-c8a09ace7ae2

Preview